Andreas Wallnoefer
Directeur/Bestuurslid bij Eyebiotech Ltd.
Actieve functies van Andreas Wallnoefer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Eyebiotech Ltd.
 Eyebiotech Ltd. BiotechnologyHealth Technology Eyebiotech Ltd. is a British clinical stage ophthalmology company that treats patients with sight-threatening diseases. The company is based in London, UK. Eyebiotech was founded in 2021 by David R. Guyer and Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Directeur/Bestuurslid | - | - |
Jeito Capital SASU
 Jeito Capital SASU Investment ManagersFinance Jeito Capital SASU (Jeito Capital) is an Independent Venture Capital firm founded in 2018 by Rafaele Tordjman and headquartered in Paris, France. | Private Equity Investor | 01-10-2021 | - |
Loopbaan van Andreas Wallnoefer
Statistieken
Internationaal
| Verenigd Koninkrijk | 2 |
| Frankrijk | 2 |
Operationeel
| Director/Board Member | 1 |
| Private Equity Investor | 1 |
Sectoraal
| Health Technology | 2 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Eyebiotech Ltd.
Eyebiotech Ltd. BiotechnologyHealth Technology Eyebiotech Ltd. is a British clinical stage ophthalmology company that treats patients with sight-threatening diseases. The company is based in London, UK. Eyebiotech was founded in 2021 by David R. Guyer and Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Health Technology |
Jeito Capital SASU
Jeito Capital SASU Investment ManagersFinance Jeito Capital SASU (Jeito Capital) is an Independent Venture Capital firm founded in 2018 by Rafaele Tordjman and headquartered in Paris, France. | Finance |
- Beurs
- Insiders
- Andreas Wallnoefer
- Ervaring
